Metraipolis › archive › dc_34bfe1eb5ce6
Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A… — Europe PMC PMID:41702836
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41702836
- DOI
- 10.1002/cam4.71637
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:55:55.086Z
- SHA-256 of the archived text
dc569f9947ef11e46ec96d52ea4beadd61e3aaa856f57e3a78b1063bf6da1216- Stable URL of this page
https://metraipolis.com/documento/dc_34bfe1eb5ce6
How to cite
Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A… — Europe PMC PMID:41702836 — Europe PMC (en), https://europepmc.org/article/MED/41702836 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_34bfe1eb5ce6 (Metraipolis archive dc_34bfe1eb5ce6, sha256 dc569f9947ef11e46ec96d52ea4beadd61e3aaa856f57e3a78b1063bf6da1216)
BibTeX
@misc{dc34bfe1eb5ce6,
title = {Efficacy and Safety of Combination Therapy With Immune Checkpoint Inhibitors and Chemotherapy With Gemcitabine and Nab-Paclitaxel in Pancreatic Cancer: A… — Europe PMC PMID:41702836},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41702836},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_34bfe1eb5ce6; sha256 dc569f9947ef11e46ec96d52ea4beadd61e3aaa856f57e3a78b1063bf6da1216},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41702836. Agents can read the archived copy with the MCP tool read_document.